Maekawa M, Tani S, Kanno T
Department of Laboratory Medicine, Hamamatsu University School of Medicine.
Rinsho Byori. 1993 Dec;41(12):1358-64.
The rapid clearance of certain releasing enzymes from blood stream may modify their usefulness as markers of disease. Serum LD isoenzyme patterns are often quite different from those in the affected tissues. Such differences result from differences in the biological half lives of the individual isoenzyme. In order to reveal such phenomena, we applied the one-compartment model to simulate the time dependent changes in the serum LD isoenzyme patterns as a most simple model. When we simulated leukemic cells as an affected origin, LD isoenzyme patterns obtained at a stage of clinical deterioration or active stage, were characterized by a high proportion of LD-2, LD-3 and LD-4, and resembled those of the original leukemic cells. In general, strong similarities in alterations of LD isoenzyme patterns were obtained between the clinical observed time course and simulated time course. These changes in LD isoenzyme patterns are practically observed in the cases of leukemia, lymphoma, and so on. If the original organs are identical, then it is change of disease stage that is responsible for modification of variable LD isoenzyme patterns. Such phenomena must therefore be noted--in doing so, we shall be able to estimate the origin of enzyme release, disease stage, and prognosis.
某些释放酶从血流中的快速清除可能会改变它们作为疾病标志物的效用。血清乳酸脱氢酶(LD)同工酶谱通常与受影响组织中的谱型有很大不同。这种差异源于各个同工酶生物学半衰期的不同。为了揭示此类现象,我们应用单室模型来模拟血清LD同工酶谱随时间的变化,这是一个最简单的模型。当我们将白血病细胞模拟为受影响的来源时,在临床病情恶化阶段或活动期获得的LD同工酶谱的特征是LD-2、LD-3和LD-4比例较高,并且与原始白血病细胞的谱型相似。一般来说,在临床观察到的时间进程和模拟的时间进程之间,LD同工酶谱的变化有很强的相似性。在白血病、淋巴瘤等病例中实际观察到了LD同工酶谱的这些变化。如果原始器官相同,那么是疾病阶段的变化导致了可变的LD同工酶谱的改变。因此必须注意此类现象——这样做,我们将能够估计酶释放的来源、疾病阶段和预后。